TrialCNS drugs2025

Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5-HT2AR Antagonist (VVZ-2471) in a Randomized, Double-Blind, First-in-Human Study.

Sungyeun Bae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.